Product Information
METHOCARBAMOL 500 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0395 per EA under NDC 31722053305. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 6, 2009. Its Orange Book therapeutic-equivalence code is AA.
Strength
500 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722053305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHOCARBAMOLApproval Type
Generic (ANDA)
FDA Application
ANDA090200FDA Approved
11/6/2009
TE Code
AA
On Market Since
3/20/2013
Pharmacological Classes
Price Statistics
The NADAC for METHOCARBAMOL 500 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0395 per EA |
|---|---|
| All-time high | $0.0948 (Sep 11, 2019) |
| All-time low | $0.0281 (Nov 20, 2024) |
| 52-week high | $0.0397 |
| 52-week low | $0.0357 |
| Median price | $0.0653 |
| Average price | $0.0614 |
| Largest weekly change | +37.5% (May 22, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methocarbamol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHOCARBAMOL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOCARBAMOL 500 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0395 per EA (NDC 31722053305), effective Sep 30, 2026.
How has the price of METHOCARBAMOL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOCARBAMOL 500 MG TABLET has declined 53.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METHOCARBAMOL 500 MG TABLET?
Since Nov 28, 2013, the NADAC for METHOCARBAMOL 500 MG TABLET has ranged from a low of $0.0281 (Nov 20, 2024) to a high of $0.0948 (Sep 11, 2019), with a median of $0.0653 per EA.
Are there cheaper alternatives to METHOCARBAMOL 500 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHOCARBAMOL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHOCARBAMOL 500 MG TABLET?
METHOCARBAMOL 500 MG TABLET (NDC 31722053305) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.